LS-LBP-002

N/A

Report date: 2026/02/06 20:01:23

Base Information

Drug NameLS-LBP-002
Drug Alias NameBMC-128LS-LBP-002LBP_002LBP-002LS_LBP_002
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Lishan Biopharmaceutical Co LtdBiomica LtdRambam Health Care Campus
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A